NCT05933200 / 2022-001539-10: A Study to Determine the Effect of Triheptanoin Compared With Even-chain, MCT on MCEs in Pediatric Patients With LC-FAOD |
|
|
| Active, not recruiting | 3 | 60 | Europe, Japan, RoW | Triheptanoin, UX007, Dojolvi, MCT Oil, Medium-chain Triglyceride | Ultragenyx Pharmaceutical Inc, Ultragenyx Pharmaceutical Inc. | Long-chain Fatty Acid Oxidation Disorders (LC-FAOD) | 09/26 | 09/26 | | |